Sullivan DR, et al. - Via this prospective, multicenter study, researchers inquired patients with treated stage I lung cancer (n=114, mean age 70 years, 65% were male), including those who received stereotactic body radiation therapy (SBRT) [n=68 (60%)] and those who received surgery [n=46 (40%)], to better understand their values and preferences regarding early stage lung cancer treatment decision making. Compared to survival or cancer recurrence, participants with early stage lung cancer more highly valued maintaining independence and quality of life (QOL). With regard to treatment selection, the options with high periprocedural mortality were accepted but not those with severe deficits affecting QOL. Patients who received SBRT or surgery commonly displayed treatment discordance. In order to promote shared decision making and assure treatment plans are consistent with patients’ goals, it is important to understand patients’ values and preferences about treatment decisions. To engage in high quality communication during lung cancer treatment discussions, clinicians require more resources.